Navigation Links
Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
Date:1/14/2011

The Case Western Reserve University/University Hospitals AIDS Clinical Trials Unit is now screening potential participants for a nationwide HIV vaccine clinical trial (HVTN505) being conducted by the HIV Vaccine Trials Network. The HIV vaccine trial is the first of its kind in Cleveland since 2003.

The trial is testing the safety and effectiveness of a combination of two HIV vaccines to see if they will stimulate an immune response to HIV or decrease the amount of virus in the blood if a person later becomes infected. Neither vaccine can cause HIV infection. The trial, which also is open in 15 other U.S. cities, is looking to enroll 1,350 gay men and transgender women. Participants must be 18-50 years old and HIV-uninfected (negative).

"Historically, vaccines have been key to ending viral epidemics," said Benigno Rodriguez, MD, an infectious disease physician at University Hospitals (UH) Case Medical Center and assistant professor of medicine at Case Western Reserve School of Medicine. "Even with good antiretroviral therapy, millions of people become newly infected each year. We cannot treat our way out of this epidemic."

"Throughout the AIDS epidemic, Greater Cleveland's gay community has consistently supported AIDS-related clinical trials. We believe that the men of Cleveland will want to stand up and learn more about HIV vaccine research. We anticipate that many will be willing to participate in this study," continued Dr. Rodriguez.

People interested in learning more about the vaccine trial should call 216-844-4444 or email info@case.edu

The vaccine trial comes to Cleveland after a year of promising developments in the worldwide search for effective new tools to help stem the AIDS epidemic, now entering its third decade. Last year, clinical trials proved some level of effectiveness for two HIV prevention strategies. The CAPRISA004 study demonstrated for the first time that a microbicide a g
'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Satellite Healthcares Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses Association
2. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
3. Visionworks(R) Brings High Quality Eye Care & Eye Wear to Western PA
4. Only women with Western Swedish breast cancer gene run higher risk of ovarian cancer
5. Case Western Reserve receives nearly $8M to help providers enable adoption of EHRs in Ohio
6. ShelterBox Responds to Earthquake in Western China
7. Western Maryland to be Featured at BIO International Convention
8. UT Southwestern researchers uncover Fragile X syndrome genes role in shaping brain
9. UT Southwestern participates in nationwide study offering free lung tumor genetic testing
10. Belly fat or hip fat -- it really is all in your genes, says UT Southwestern researcher
11. Novel anti-malarial drug candidate found by UT Southwestern researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
(Date:11/27/2014)... 27, 2014 This is a ... Insulin industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry covers information on policy, plans for ... structure and much more. , This ...
(Date:11/27/2014)... At The Little Gym, we know that ... no surprise when a recent study confirmed that regular ... Journal of Pediatrics found that “Promoting physical ... the school years may be important not only for ... monitored two groups of children; those that were engaging ...
(Date:11/27/2014)... November 27, 2014 The Emerald Cup ... Up-Close Look At This Year’s Entries | SKUNK Magazine ... Stay For Two At Their Resort, Pure Garden, In ... or L.A.-based Hempcon, The Emerald Cup is presented by ... draws much of California’s original cannabis industry." – SFGate, ...
(Date:11/27/2014)... 27, 2014 In addition to a ... important gift home this holiday season and become educated ... Visiting with relatives over the holidays may raise questions ... Although some change in cognitive ability can occur with ... normal aging. Recognizing the difference between normal aging and ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... mid-October, ahead of vaccine delivery , THURSDAY, Sept. 10 (HealthDay ... flu outbreak is expected in October, but a planned vaccine ... suggests. , The first batch of the new H1N1 vaccine, ... according to the U.S. Centers for Disease Control and Prevention. ...
... Boston Scientific Corporation (NYSE: BSX ) is scheduled to ... , Ray Elliott, President and Chief Executive Officer ... participate in a 35-minute discussion about the Company on Tuesday, September ... , A live webcast of this discussion will be ...
... ... reconstruction, quicker recovery and more natural knee motion post-surgery , ... Evanston, Illinois (Vocus) -- NorthShore University ... use a new and innovative robotic technology for minimally-invasive partial knee replacement ...
... , , WOODCLIFF ... today announced that it has received final approval from the U.S. ... nateglinide tablets. Nateglinide is a generic version of Novartis, Starlix(R). ... to IMS Health data. Par will begin shipping the 60mg ...
... , , WARSAW, Ind., ... leading independent provider of products to the global orthopedic device industry and ... Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial ... at the Grand Hyatt Grand Central Hotel in New York City on ...
... , , NEW DELHI, Sept. 10 ... in India -- today announced an inspiring list of speakers for the ... theme of TEDIndia is "The Future Beckons." , , ... from diverse disciplines. Doctor and researcher Hans Rosling will share ...
Cached Medicine News:Health News:Swine Flu Shots May Come Too Late to Stem Fall Outbreak: Study 2Health News:Swine Flu Shots May Come Too Late to Stem Fall Outbreak: Study 3Health News:Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference 2Health News:NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 2Health News:NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 3Health News:NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 4Health News:Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R) 2Health News:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 2Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 3Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 4Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 5Health News:TEDIndia Announces List of Inspiring Speakers from Across the Globe 6
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
(Date:11/26/2014)... , Nov. 25, 2014 ... focused on the development of mobile diagnostic ... testing in hospital and pre-hospital settings, today ... (ISO) 13485:2003 certification.  The certification was awarded ... of the world,s leading certification bodies. ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... is equipped with a new 1/2" Progressive ... excellent sensitivity (1280 (H) x 960 (V) ... uncompressed, high-resolution, digital color images and features ... an exposure range from 1/100,000 to 17.5 ...
... DP70 brings you the latest in imaging technology ... The DP70 offers high resolution, high sensitivity, and ... demanding applications, including fluorescence. CCD ... Bit Depth - 36-bit ...
4 megapixel zoom digicam with a 4x optical zoom, Effective pixels:4.0 million CCD:1/1.8-in. type (4.13 million total pixels), Max Image size:2272 (2,272 x 1,704 pixels), Lens:4x Zoom-Nikkor; f = 7.85...
... superb stand-alone digital camera with networking capability ... or remote locations. Image acquisition and camera ... operates independently or attaches directly to a ... to capture and transfer images. Sharing images ...
Medicine Products: